GGrantIndex
← Leaderboards

Igor I Slukvin

University Of Wisconsin Madison

$16,564,924
Attributed
$20,496,859
Total exposure
40
Grants
36
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY200524
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$20,496,859 · 40

By mechanism

R01$10,172,503 · 5
R24$3,341,482 · 1
U01$2,302,970 · 1
P01$2,015,371 · 1
P51$1,344,053 · 28
R21$824,355 · 2

Most similar at University Of Wisconsin Madison

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsHematopoieticStem CellsSourceHuman Embryonic Stem CellResearch PersonnelIn VitroInduced Pluripotent Stem CellMolecularUnited States National Institutes Of HealthBaseHematological DiseaseGenesProgenitorCell LineStagingGenerationsEngraftmentInstitutionHematopoietic Stem CellsResourcesGrantFundingEmbryo

Grant awards (70)

Phase Changing Ultrasound Contrast Agents for Deep Tissue Imaging of Cellular Immunotherapies$490,381
R01 · FY2024 · CA
Development of iPSC-derived iNKT cells to promote hematopoietic engraftment$194,375
R21 · FY2023 · AI
Transplantation of MHC Homozygous Vascular Progenitors in Primates$1,148,048
U01 · FY2022 · HL · contact PI
Development of iPSC-derived iNKT cells to promote hematopoietic engraftment$233,250
R21 · FY2022 · AI
Transplantation of MHC Homozygous Vascular Progenitors in Primates$1,154,922
U01 · FY2021 · HL · contact PI
Molecular Determinants of Hemogenic Endothelium$495,137
R01 · FY2021 · HL · contact PI
Molecular Determinants of Hemogenic Endothelium$495,137
R01 · FY2020 · HL · contact PI
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS$736,081
R24 · FY2019 · OD · contact PI
Nonhuman Primate Model for Preclinical Evaluation of Haplotype-Based iPSC Banking for HLA-matched Blood Products$625,820
R01 · FY2019 · HL · contact PI
Molecular Determinants of Hemogenic Endothelium$495,137
R01 · FY2019 · HL · contact PI
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS$745,261
R24 · FY2018 · OD · contact PI
Nonhuman Primate Model for Preclinical Evaluation of Haplotype-Based iPSC Banking for HLA-matched Blood Products$632,588
R01 · FY2018 · HL · contact PI
Molecular Determinants of Hemogenic Endothelium$495,137
R01 · FY2018 · HL · contact PI
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS$755,670
R24 · FY2017 · OD · contact PI
iPSC-based blood regenerative therapies for AIDS$694,457
R01 · FY2017 · HL · contact PI
Nonhuman Primate Model for Preclinical Evaluation of Haplotype-Based iPSC Banking for HLA-matched Blood Products$631,092
R01 · FY2017 · HL · contact PI
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS$340,053
R24 · FY2017 · OD · contact PI
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS$764,417
R24 · FY2016 · OD · contact PI
iPSC-based blood regenerative therapies for AIDS$694,457
R01 · FY2016 · HL · contact PI
Nonhuman Primate Model for Preclinical Evaluation of Haplotype-Based iPSC Banking for HLA-matched Blood Products$601,216
R01 · FY2016 · HL · contact PI
iPSC-based blood regenerative therapies for AIDS$684,039
R01 · FY2015 · HL · contact PI
iPSC-based blood regenerative therapies for AIDS$627,832
R01 · FY2014 · HL · contact PI
iPSC-based blood regenerative therapies for AIDS$36,386
R01 · FY2014 · HL · contact PI
iPSC-based blood regenerative therapies for AIDS$622,020
R01 · FY2013 · HL · contact PI
ES Cell-Specific Genes and Reprogramming of Human Somatic Cells$387,040
P01 · FY2012 · GM · contact PI
ES Cell-Specific Genes and Reprogramming of Human Somatic Cells$410,814
P01 · FY2011 · GM · contact PI
Hematopoietic commitment of human embryonic stem cells$373,194
R01 · FY2011 · HL · contact PI
DETERMINANTS OF SELF-RENEWAL, DIFFERENTIATION, AND REPROGRAMMING OF HESCS$125,113
P51 · FY2011 · RR · contact PI
HEMATOPOIETIC COMMITMENT OF HUMAN EMBRYONIC STEM CELLS$106,304
P51 · FY2011 · RR · contact PI
ES Cell-Specific Genes and Reprogramming of Human Somatic Cells$415,051
P01 · FY2010 · GM · contact PI
Hematopoietic commitment of human embryonic stem cells$370,527
R01 · FY2010 · HL · contact PI
DENDRITIC CELLS FROM HUMAN EMBRYONIC STEM CELLS$41,308
P51 · FY2010 · RR · contact PI
INDUCED PLURIPOTENT STEM CELLS (IPS CELLS) FOR TREATING LUPUS$41,308
P51 · FY2010 · RR · contact PI
DETERMINANTS OF SELF-RENEWAL, DIFFERENTIATION, AND REPROGRAMMING OF HESCS$41,308
P51 · FY2010 · RR · contact PI
INDUCED PLURIPOTENT STEM CELL (IPSC) THERAPY FOR BLOOD DISORDERS$41,308
P51 · FY2010 · RR · contact PI
GENERATION OF RED BLOOD CELLS FROM HUMAN EMBRYONIC STEM CELLS$41,308
P51 · FY2010 · RR · contact PI
HEMATOPOIETIC COMMITMENT OF HUMAN EMBRYONIC STEM CELLS$30,981
P51 · FY2010 · RR · contact PI
ES Cell-Specific Genes and Reprogramming of Human Somatic Cells$407,119
P01 · FY2009 · GM · contact PI
Hematopoietic commitment of human embryonic stem cells$367,925
R01 · FY2009 · HL · contact PI
DETERMINANTS OF SELF-RENEWAL, DIFFERENTIATION, AND REPROGRAMMING OF HESCS$46,835
P51 · FY2009 · RR · contact PI
INDUCED PLURIPOTENT STEM CELL (IPSC) THERAPY FOR BLOOD DISORDERS$46,835
P51 · FY2009 · RR · contact PI
DENDRITIC CELLS FROM HUMAN EMBRYONIC STEM CELLS$46,835
P51 · FY2009 · RR · contact PI
HEMATOPOIETIC COMMITMENT OF HUMAN EMBRYONIC STEM CELLS$46,835
P51 · FY2009 · RR · contact PI
DECIDUAL MACROPHAGES IN PRIMATE PREGNANCY$46,835
P51 · FY2009 · RR · contact PI
GENERATION OF RED BLOOD CELLS FROM HUMAN EMBRYONIC STEM CELLS$46,835
P51 · FY2009 · RR · contact PI
INDUCED PLURIPOTENT STEM CELLS (IPS CELLS) FOR TREATING LUPUS$46,835
P51 · FY2009 · RR · contact PI
Hematopoietic and cardiac stem cells from human pluripotent stem cells$37,125
R03 · FY2009 · HL · contact PI
ES Cell-Specific Genes and Reprogramming of Human Somatic Cells$395,347
P01 · FY2008 · GM · contact PI
Hematopoietic commitment of human embryonic stem cells$365,379
R01 · FY2008 · HL · contact PI
Dendritic Cells from Human Embryonic Stem Cells$216,740
R21 · FY2008 · HL · contact PI
GENERATION OF RED BLOOD CELLS FROM HUMAN EMBRYONIC STEM CELLS$40,957
P51 · FY2008 · RR · contact PI
HEMATOPOIETIC COMMITMENT OF HUMAN EMBRYONIC STEM CELLS$40,957
P51 · FY2008 · RR · contact PI
DECIDUAL MACROPHAGES IN PRIMATE PREGNANCY$40,957
P51 · FY2008 · RR · contact PI
DENDRITIC CELLS FROM HUMAN EMBRYONIC STEM CELLS$40,957
P51 · FY2008 · RR · contact PI
INDUCED PLURIPOTENT STEM CELL (IPSC) THERAPY FOR BLOOD DISORDERS$40,957
P51 · FY2008 · RR · contact PI
Hematopoietic commitment of human embryonic stem cells$374,642
R01 · FY2007 · HL · contact PI
Dendritic Cells from Human Embryonic Stem Cells$179,990
R21 · FY2007 · HL · contact PI
Decidual macrophages in primate pregnancy$91,800
K08 · FY2007 · HD · contact PI
GENERATION OF RED BLOOD CELLS FROM HUMAN EMBRYONIC STEM CELLS$62,968
P51 · FY2007 · RR · contact PI
DENDRiTIC CELLS FROM HUMAN EMBRYONIC STEM CELLS$62,968
P51 · FY2007 · RR · contact PI
HEMOTROPOIETIC COMMITMENT OF HUMAN EMBRYONIC STEM CELLS$62,967
P51 · FY2007 · RR · contact PI
DECIDUAL MACROPHAGES IN PRIMATE PREGNANCY$62,967
P51 · FY2007 · RR · contact PI
Decidual macrophages in primate pregnancy$91,800
K08 · FY2006 · HD · contact PI
HEMATOPOIETIC COMMITMENT OF HUMAN EMBRYONIC STEM CELLS$27,215
P51 · FY2006 · RR · contact PI
DECIDUAL MACROPHAGES IN PRIMATE PREGNANCY$27,215
P51 · FY2006 · RR · contact PI
Decidual macrophages in primate pregnancy$91,800
K08 · FY2005 · HD
HEMATOPOIETIC COMMITMENT OF HUMAN EMBRYONIC STEM CELLS$34,795
P51 · FY2005 · RR
Decidual macrophages in primate pregnancy$91,800
K08 · FY2004 · HD
DECIDUAL MACROPHAGES IN PRIMATE PREGNANCY$1,390
P51 · FY2004 · RR
Decidual macrophages in primate pregnancy$91,800
K08 · FY2003 · HD